Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non–Small-Cell Lung Cancer

Published:2015-11 Issue:6 Volume:16 Page:e253-e258
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Mattes Malcolm D.^ORCID,Moshchinsky Ariella B.^ORCID,Ahsanuddin Salma,Rizk Nabil P.,Foster Amanda,Wu Abraham J.,Ashamalla Hani^ORCID,Weber Wolfgang A.,Rimner Andreas

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference38 articles.

1. Regional lymph node classification for lung cancer staging;Mountain;Chest,1997

2. Invasive staging of non–small cell lung cancer: a review of the current evidence;Toloza;Chest,2003

3. Diagnostic performance of integrated positron emission tomography/computed tomography for mediastinal lymph node staging in non–small cell lung cancer: a bivariate systematic review and meta-analysis;Lv;J Thorac Oncol,2011

4. Positron emission tomography/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response;Truong;J Thorac Imaging,2011

5. PET-CT in the staging and treatment of non–small-cell lung cancer;Ibeas;Clin Transl Oncol,2011

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of mediastinal tumor burden and lymphatic spread in locally advanced non-small-cell lung cancer: A secondary analysis of the multicenter randomized PET-Plan trial;Radiotherapy and Oncology;2024-11

2. Prospective Evaluation of Quantitative F-18-FDG-PET/CT for Pre-Operative Thoracic Lymph Node Staging in Patients with Lung Cancer as a Target for Computer-Aided Diagnosis;Diagnostics;2023-03-27

3. A Comparative Evaluation of Mediastinal Nodal SUVmax and Derived Ratios from 18F-FDG PET/CT Imaging to Predict Nodal Metastases in Non-Small Cell Lung Cancer;Diagnostics;2023-03-23

4. Frailty Index is Associated with Treatment Decisions for Stage I Non-Small Cell Lung Cancer at a High-Burden Safety-Net Hospital;Clinical Lung Cancer;2023-03

5. Lymph node metastasis risk factors in clinical stage IA3 lung adenocarcinoma;J CANCER RES THER;2023